TESAMORELIN

Visceral fat loss and metabolic health Tesamorelin is a stabilized synthetic peptide analogue of the hypothalamic peptide, Growth Hormone Releasing Hormone GHRH indicated for the reduction of excess abdominal fat in HIV infected patients with lipodystrophy. Lipodystrophy is a metabolic condition characterized by insulin resistance, fat redistribution, and hyperlipidaemia associated with antiretroviral therapy for HIV infection. Tesamorelin is made with growth hormone releasing factor GRF . Tesamorelin is used to reduce excess fat around the stomach that is caused by taking certain HIV medications. This condition is also called lipodystrophy LYE poe DIS troe fee . HGH releasing hormone target adipose fat cells